The Binding between the Stem Regions of Human Growth Hormone (GH) Receptor Compensates for the Weaker Site 1 Binding of 20-kDa Human GH (hGH) than That of 22-kDa hGH*

Despite the lower site 1 affinity of the 20-kDa human growh hormone (20K-hGH) for the hGH receptor (hGHR), 20K-hGH has the same hGHR-mediated activity as 22-kDa human GH (22K-hGH) at low hGH concentration and even higher activity at high hGH concentration. This study was performed to elucidate the reason why 20K-hGH can activate hGHR to the same level as 22K-hGH. To answer the question, we hypothesized that the binding between the stem regions of hGHR could compensate for the weaker site 1 binding of 20K-hGH than that of 22K-hGH in the sequential binding with hGHR. To demonstrate it, we prepared 15 types of alanine-substituted hGHR gene at the stem region and stably transfected them into Ba/F3 cells. Using these cells, we measured and compared the cell proliferation activities between 20K- and 22K-hGH. As a result, the activity of 20K-hGH was markedly reduced than that of 22K-hGH in three types of mutant hGHR (T147A, H150A, and Y200A). Regarding these mutants, the dissociation constant of hGH at the first and second step (KD1 and KD2) in the sequential binding with two hGHRs was predicted based on the mathematical cell proliferation model and computational simulation. Consequently, it was revealed that the reduction of the activity in 20K-hGH was attributed to the change of not KD1 but KD2. In conclusion, these findings support our hypothesis, which can account for the same potencies for activating hGHR between 20K- and 22K-hGH, although the site 1 affinity of 20K-hGH is lower than that of 22K-hGH.

[1]  K. Matsumoto,et al.  Analysis of binding properties between 20 kDa human growth hormone (hGH) and hGH receptor (hGHR): the binding affinity for hGHR extracellular domain and mode of receptor dimerization. , 1999, Journal of Molecular Endocrinology.

[2]  J. Wells,et al.  Growth hormone binding affinity for its receptor surpasses the requirements for cellular activity. , 1999, Biochemistry.

[3]  T. Clackson,et al.  Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity. , 1998, Journal of molecular biology.

[4]  Y. Takahashi,et al.  The full agonistic effect of recombinant 20 kDa human growth hormone (hGH) on CHO cells stably transfected with hGH receptor cDNA , 1997, Molecular and Cellular Endocrinology.

[5]  K. Nakashima,et al.  Secretion of authentic 20-kDa human growth hormone (20K hGH) in Escherichia coli and properties of the purified product. , 1997, Journal of biotechnology.

[6]  M. Waters,et al.  The Role of Receptor Dimerization Domain Residues in Growth Hormone Signaling* , 1997, The Journal of Biological Chemistry.

[7]  M. Waters,et al.  A Growth Hormone Agonist Produced by Targeted Mutagenesis at Binding Site 1. , 1995, The Journal of Biological Chemistry.

[8]  D. Levy,et al.  Prolactin, growth hormone, erythropoietin and granulocyte‐macrophage colony stimulating factor induce MGF‐Stat5 DNA binding activity. , 1995, The EMBO journal.

[9]  M. Preece,et al.  A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH‐binding activity by abolishing receptor homodimerization. , 1994, The EMBO journal.

[10]  D. Meyer,et al.  Growth Hormone Induces a Dna Binding Factor Related to the Interferon-stimulated 91-kda Transcription Factor* Materiazs-3t3-f442a Cells Were Provided , 2022 .

[11]  J. Wells,et al.  Comparison of a structural and a functional epitope. , 1993, Journal of molecular biology.

[12]  O. Silvennoinen,et al.  Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase , 1993, Cell.

[13]  D. Goeddel,et al.  Rational design of potent antagonists to the human growth hormone receptor. , 1992, Science.

[14]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[15]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[16]  K. Clauser,et al.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. , 1991, Science.

[17]  G. Baumann.  Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. , 1991, Endocrine reviews.

[18]  P. Argos,et al.  Suggestions for "safe" residue substitutions in site-directed mutagenesis. , 1991, Journal of molecular biology.

[19]  J. Wells,et al.  High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. , 1989, Science.

[20]  M. Tanaka,et al.  Molecular cloning of cDNA encoding 20 kDa variant human growth hormone and the alternative splicing mechanism. , 1988, Biochimica et biophysica acta.

[21]  D. Moore,et al.  Human growth hormone DNA sequence and mRNA structure: possible alternative splicing. , 1981, Nucleic acids research.

[22]  L. J. Lewis,et al.  The 20,000-dalton variant of human growth hormone: location of the amino acid deletions. , 1980, Biochemical and biophysical research communications.

[23]  L. Bonewald,et al.  A naturally occurring structural variant of human growth hormone. , 1978, The Journal of biological chemistry.